OncoXchange welcomes you to participate in the CPD-accredited program “AI-assisted drug development and repurposing in Breast Cancer”, presented by Prof. Evelyne Yehudit Bischof, MD, MHP, FEFIM. Based on an online AI Educational Series Prepared in 2021, Dr. Bischof reviews the current therapeutic approaches in BC, drug repurposing vs. repositioning, Drug repurposing for Breast Cancer looking at the new frontiers, and emerging platforms such as; Ai in drug development and repurposing, translating omics-data into drug predictions, In-silico Clinical Trials predictions, and finally looking at the challenges and perspectives
